PAGE 11 OF 11 Nucleic Acids Research, 2009, Vol. 37, No. 12 e89 56. Brenner,A.J., Paladugu,A., Wang,H., Olopade,O.I., Dreyling,M.H. and Aldaz,C.M. (1996) Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. Clin. Cancer Res., 2, 1993–1998. 57. Dammann,R., Yang,G. and Pfeifer,G.P. (2001) Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res., 61, 3105–3109. 58. Silva,J., Silva,J.M., Dominguez,G., Garcia,J.M., Cantos,B., Rodriguez,R., Larrondo,F.J., Provencio,M., Espana,P. and Bonilla,F. (2003) Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. J. Pathol., 199, 289–297. 59. Yekta,S., Shih,I.H. and Bartel,D.P. (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science, 304, 594–596. 60. Fujino,T., Yamazaki,Y., Largaespada,D.A., Jenkins,N.A., Copeland,N.G., Hirokawa,K. and Nakamura,T. (2001) Inhibition of myeloid diﬀerentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp. Hematol., 29, 856–863. 61. Knoepﬂer,P.S., Sykes,D.B., Pasillas,M. and Kamps,M.P. (2001) HoxB8 requires its Pbx-interaction motif to block diﬀerentiation of primary myeloid progenitors and of most cell line models of mye- loid diﬀerentiation. Oncogene, 20, 5440–5448. 62. Mattila,P.K., Salminen,M., Yamashiro,T. and Lappalainen,P. (2003) Mouse MIM, a tissue-speciﬁc regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain. J. Biol. Chem., 278, 8452–8459.